ZVRA logo

Zevra Therapeutics (ZVRA) Depreciation And Amortization

Annual D&A

$1.01 M
+$62.00 K+6.57%

December 31, 2023

Summary

Performance

1-Year Change

+6.57%

3-Year Change

+268.5%

5-Year Change

+210.49%

15-Year Change

+199.4%

ZVRA Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.36%
ZVRA annual depreciation & amortization is higher than 39.36% of companies in Healthcare sector

High & Low

All-time High

$1.01 M
ZVRA annual depreciation & amortization is currently at an all-time high

3-Year Low

$257.00 K
ZVRA annual depreciation & amortization is currently +291.44% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ZVRA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
ZVRA next annual earnings announcement is scheduled for Mar 28, 2025

Related metrics

Annual Total Expenses

$77.06 M
ZVRA annual total expenses is $77.06 million

Annual Operating Expenses

$74.12 M
ZVRA annual total operating expenses is $74.12 million

Annual Cost Of Goods Sold

$2.94 M
ZVRA annual cost of goods sold is $2.94 million

Annual Interest Expense

$1.50 M
ZVRA annual interest expense is $1.50 million

Quarterly D&A

$1.62 M
+$55.00 K+3.52%

September 30, 2024

Summary

Performance

3-Month Change

+3.52%

1-Year Change

+105.46%

3-Year Change

+105.46%

5-Year Change

+105.46%

ZVRA Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.56%
ZVRA quarterly depreciation & amortization is higher than 65.56% of companies in Healthcare sector

High & Low

All-time High

$1.62 M
ZVRA quarterly depreciation & amortization is currently at an all-time high

3-Year Low

$62.00 K
ZVRA quarterly depreciation & amortization is currently +2508.06% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ZVRA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
ZVRA next earnings announcement is scheduled for Mar 28, 2025

Related metrics

Quarterly Total Expenses

$31.00 M
ZVRA quarterly total expenses is $31.00 million

Quarterly Operating Expenses

$28.70 M
ZVRA quarterly total operating expenses is $28.70 million

Quarterly Cost Of Goods Sold

$2.30 M
ZVRA quarterly cost of goods sold is $2.30 million

Quarterly Interest Expense

$2.31 M
ZVRA quarterly interest expense is $2.31 million

TTM D&A

$5.53 M
+$1.55 M+39.14%

September 30, 2024

Summary

Performance

3-Month Change

+39.14%

1-Year Change

+449.5%

3-Year Change

+449.5%

5-Year Change

+449.5%

ZVRA TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.69%
ZVRA TTM depreciation & amortization is higher than 62.69% of companies in Healthcare sector

High & Low

All-time High

$5.53 M
ZVRA TTM depreciation & amortization is currently at an all-time high

3-Year Low

$257.00 K
ZVRA TTM depreciation & amortization is currently +2050.97% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ZVRA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
ZVRA next earnings announcement is scheduled for Mar 28, 2025

Related metrics

Annual Total Expenses

$77.06 M
ZVRA annual total expenses is $77.06 million

Annual Operating Expenses

$74.12 M
ZVRA annual total operating expenses is $74.12 million

TTM Cost Of Goods Sold

$8.05 M
ZVRA TTM cost of goods sold is $8.05 million

TTM Interest Expense

$5.91 M
ZVRA TTM interest expense is $5.91 million

ZVRA Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.6%+105.5%+449.5%
3 y3 years+268.5%+105.5%+449.5%
5 y5 years+210.5%+105.5%+449.5%

ZVRA Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+291.4%at high+2508.1%at high+2051.0%
5 y5-yearat high+291.4%at high+2508.1%at high+2051.0%
alltimeall timeat high+1379.4%at high+8883.3%at high>+9999.0%

Zevra Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.62 M(+3.5%)
$5.53 M(+39.1%)
Jun 2024
-
$1.56 M(0.0%)
$3.97 M(+59.6%)
Mar 2024
-
$1.56 M(+98.5%)
$2.49 M(+147.4%)
Dec 2023
$1.01 M(+6.6%)
$787.00 K(+1169.4%)
$1.01 M(+93.8%)
Sep 2023
-
$62.00 K(-20.5%)
$519.00 K(-39.3%)
Jun 2023
-
$78.00 K(-1.3%)
$855.00 K(-10.8%)
Mar 2023
-
$79.00 K(-73.7%)
$958.00 K(+1.5%)
Dec 2022
$944.00 K(+267.3%)
$300.00 K(-24.6%)
$944.00 K(+33.3%)
Sep 2022
-
$398.00 K(+119.9%)
$708.00 K(+88.8%)
Jun 2022
-
$181.00 K(+178.5%)
$375.00 K(+45.3%)
Mar 2022
-
$65.00 K(+1.6%)
$258.00 K(+0.4%)
Dec 2021
$257.00 K(-5.9%)
-
-
Dec 2021
-
$64.00 K(-1.5%)
$257.00 K(-0.8%)
Sep 2021
-
$65.00 K(+1.6%)
$259.00 K(-0.8%)
Jun 2021
-
$64.00 K(0.0%)
$261.00 K(-1.5%)
Mar 2021
-
$64.00 K(-3.0%)
$265.00 K(-2.9%)
Dec 2020
$273.00 K(-10.2%)
$66.00 K(-1.5%)
$273.00 K(-3.2%)
Sep 2020
-
$67.00 K(-1.5%)
$282.00 K(-3.1%)
Jun 2020
-
$68.00 K(-5.6%)
$291.00 K(-2.3%)
Mar 2020
-
$72.00 K(-4.0%)
$298.00 K(-2.0%)
Dec 2019
$304.00 K
$75.00 K(-1.3%)
$304.00 K(-1.3%)
Sep 2019
-
$76.00 K(+1.3%)
$308.00 K(-1.0%)
DateAnnualQuarterlyTTM
Jun 2019
-
$75.00 K(-3.8%)
$311.00 K(-2.5%)
Mar 2019
-
$78.00 K(-1.3%)
$319.00 K(-1.5%)
Dec 2018
$324.00 K(-3.6%)
$79.00 K(0.0%)
$324.00 K(-1.8%)
Sep 2018
-
$79.00 K(-4.8%)
$330.00 K(-2.4%)
Jun 2018
-
$83.00 K(0.0%)
$338.00 K(-0.3%)
Mar 2018
-
$83.00 K(-2.4%)
$339.00 K(+0.9%)
Dec 2017
$336.00 K(+92.0%)
$85.00 K(-2.3%)
$336.00 K(+2.1%)
Sep 2017
-
$87.00 K(+3.6%)
$329.00 K(+15.8%)
Jun 2017
-
$84.00 K(+5.0%)
$284.00 K(+24.0%)
Mar 2017
-
$80.00 K(+2.6%)
$229.00 K(+30.9%)
Dec 2016
$175.00 K(+108.3%)
$78.00 K(+85.7%)
$175.00 K(+45.8%)
Sep 2016
-
$42.00 K(+44.8%)
$120.00 K(+21.2%)
Jun 2016
-
$29.00 K(+11.5%)
$99.00 K(+10.0%)
Mar 2016
-
$26.00 K(+13.0%)
$90.00 K(+7.1%)
Dec 2015
$84.00 K(+12.0%)
$23.00 K(+9.5%)
$84.00 K(+5.0%)
Sep 2015
-
$21.00 K(+5.0%)
$80.00 K(+3.9%)
Jun 2015
-
$20.00 K(0.0%)
$77.00 K(+1.3%)
Mar 2015
-
$20.00 K(+5.3%)
$76.00 K(+1.3%)
Dec 2014
$75.00 K(+10.3%)
$19.00 K(+5.6%)
$75.00 K(+33.9%)
Sep 2014
-
$18.00 K(-5.3%)
$56.00 K(+47.4%)
Jun 2014
-
$19.00 K(0.0%)
$38.00 K(+100.0%)
Mar 2014
-
$19.00 K
$19.00 K
Dec 2013
$68.00 K
-
-

FAQ

  • What is Zevra Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Zevra Therapeutics?
  • What is Zevra Therapeutics annual D&A year-on-year change?
  • What is Zevra Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Zevra Therapeutics?
  • What is Zevra Therapeutics quarterly D&A year-on-year change?
  • What is Zevra Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Zevra Therapeutics?
  • What is Zevra Therapeutics TTM D&A year-on-year change?

What is Zevra Therapeutics annual depreciation & amortization?

The current annual D&A of ZVRA is $1.01 M

What is the all time high annual D&A for Zevra Therapeutics?

Zevra Therapeutics all-time high annual depreciation & amortization is $1.01 M

What is Zevra Therapeutics annual D&A year-on-year change?

Over the past year, ZVRA annual depreciation & amortization has changed by +$62.00 K (+6.57%)

What is Zevra Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of ZVRA is $1.62 M

What is the all time high quarterly D&A for Zevra Therapeutics?

Zevra Therapeutics all-time high quarterly depreciation & amortization is $1.62 M

What is Zevra Therapeutics quarterly D&A year-on-year change?

Over the past year, ZVRA quarterly depreciation & amortization has changed by +$830.00 K (+105.46%)

What is Zevra Therapeutics TTM depreciation & amortization?

The current TTM D&A of ZVRA is $5.53 M

What is the all time high TTM D&A for Zevra Therapeutics?

Zevra Therapeutics all-time high TTM depreciation & amortization is $5.53 M

What is Zevra Therapeutics TTM D&A year-on-year change?

Over the past year, ZVRA TTM depreciation & amortization has changed by +$4.52 M (+449.50%)